APOPTOGENTH LIMITED
CopyKey Data
Status
Company No.
Incorporation date
Size
Contacts
Registered address
Total Assets
No recordsNumber of employees
No recordsCash in Bank
No recordsConfirmation
Accounts
Financial Ratios
No financial ratios available
This company has not submitted financial statements or the data is not publicly available. Please check back later – the information may be updated.
People
Officers
Person | Title | Period | Connections |
|---|---|---|---|
Dr Nadia Orsi | Director | 18/02/2025 - Present | 15 |
Lorger, Mihaela, Dr | Director | 18/02/2025 - Present | - |
Faulkner, James Duncan Bruce, Dr | Director | 18/09/2025 - Present | - |
Persons with Significant Control
Similar companies
Category:
Post-harvest crop activitiesComp. code:
03185729Reg. date:
15/04/1996Turnover:
-No. of employees:
-Category:
Silviculture and other forestry activitiesComp. code:
12543378Reg. date:
01/04/2020Turnover:
-No. of employees:
-Category:
Mixed farmingComp. code:
SC127217Reg. date:
12/09/1990Turnover:
-No. of employees:
-Category:
Growing of other non-perennial cropsComp. code:
SC278017Reg. date:
06/01/2005Turnover:
-No. of employees:
-Category:
Mixed farmingComp. code:
02153348Reg. date:
07/08/1987Turnover:
-No. of employees:
-Description
About APOPTOGENTH LIMITED
APOPTOGENTH LIMITED is an(a) Active company incorporated on 18/02/2025 with the registered office located at Nexus, Discovery Way, Leeds LS2 3AA. There are currently 3 active directors according to the latest confirmation statement. Number of employees Unknown.Frequently Asked Questions
What is the current status of APOPTOGENTH LIMITED?
APOPTOGENTH LIMITED is currently Active. It was registered on 18/02/2025 .
Where is APOPTOGENTH LIMITED located?
APOPTOGENTH LIMITED is registered at Nexus, Discovery Way, Leeds LS2 3AA.
What does APOPTOGENTH LIMITED do?
APOPTOGENTH LIMITED operates in the Research and experimental development on biotechnology (72.11 - SIC 2007) sector.
What is the latest filing for APOPTOGENTH LIMITED?
The latest filing was on 01/04/2026: Statement of capital following an allotment of shares on 2026-03-31.